Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer

M Morton, J Patterson, J Sciuva, J Perni, F Backes… - Gynecologic …, 2023 - Elsevier
Patients with gynecologic cancers are at risk for malnutrition, cancer cachexia, and
sarcopenia. Accumulating data supports that malnourished patients with gynecologic cancer …

[HTML][HTML] Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation

F Zeng, A Wade, K Harbert, S Patel, JS Holley… - Scientific Reports, 2024 - nature.com
To test the hypothesis that genetic and pharmacological modulation of the classical
cannabinoid type 1 (CB1) and 2 (CB2) receptors attenuate cancer-induced bone pain, we …

[HTML][HTML] A zebrafish HCT116 xenograft model to predict anandamide outcomes on colorectal cancer

F Maradonna, CM Fontana, F Sella, C Giommi… - Cell Death & …, 2022 - nature.com
Colon cancer is one of the leading causes of death worldwide. In recent years, cannabinoids
have been extensively studied for their potential anticancer effects and symptom …

[HTML][HTML] Marijuana and cannabidiol use prevalence and symptom management among patients with cancer

TM Brasky, AM Newton, S Conroy, A Adib… - Cancer Research …, 2023 - AACR
Symptoms such as pain, nausea, and anxiety are common in individuals with cancer.
Treatment of these issues is often challenging. Cannabis products may be helpful in …

[HTML][HTML] Perspectives on challenges in cannabis drug delivery systems: Where are we?

M Palrasu, L Wright, M Patel, L Leech… - Medical Cannabis and …, 2022 - karger.com
Cannabis and its natural derivatives have emerged as promising therapeutics for multiple
pathological and nonpathological medical conditions. For example, cannabinoids, the most …

[HTML][HTML] Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature

B Hanganu, DE Lazar, IS Manoilescu, V Mocanu… - Cancers, 2022 - mdpi.com
Simple Summary In the field of oncology, preclinical research has shown that cannabis and
cannabinoids modulate signaling pathways involved in cell proliferation, migration, invasion …

[HTML][HTML] Prevention of taste alterations in patients with cancer receiving Paclitaxel-or Oxaliplatin-based chemotherapy—A pilot trial of cannabidiol

HSH Dominiak, SD Hasselsteen, SW Nielsen… - Nutrients, 2023 - mdpi.com
Introduction: Taste alteration is a common adverse effect of chemotherapy. This study aimed
to investigate the effect of cannabidiol (CBD) on Lean Body Mass (LBM), and taste …

[HTML][HTML] Use of cannabis and cannabinoids for treatment of cancer

V Cherkasova, B Wang, M Gerasymchuk, A Fiselier… - Cancers, 2022 - mdpi.com
Simple Summary Cancer is a disease which affects approximately 40% of people in their
lifetime. Chemotherapy, the primary choice for treatment of cancer, is often ineffective or/and …

Cannabis use among cancer patients and survivors in the United States: a systematic review

S Amin, SW Chae, CT Kawamoto… - JNCI Cancer …, 2024 - academic.oup.com
Background How cannabis products are being used by cancer patients and survivors in the
United States is poorly understood. This study reviewed observational data to understand …

GI symptoms in pancreatic cancer

VT Chang, C Sandifer, F Zhong - Clinical Colorectal Cancer, 2023 - Elsevier
This review will apply a multidisciplinary approach to GI symptoms with attention to symptom
assessment (instruments and qualitative aspects), differential diagnosis, and recent findings …